Armata Pharmaceuticals (ARMP) Return on Capital Employed [ROCE] (2009 - 2026)
Armata Pharmaceuticals' Return on Capital Employed [ROCE] came in at -58.07% for Q1 2026, down 8.73 percentage points from the prior quarter.
Powered by 
Analysis
Armata Pharmaceuticals (ARMP) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For FY2025, Armata Pharmaceuticals' Return on Capital Employed [ROCE] was -50.38%, up 45.73 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a five-year change of +33.36 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -96.12% in FY2024 (-45.41 pp), -50.71% in FY2023 (+13.07 pp), -63.78% in FY2022 (-15.97 pp) and -47.81% in FY2021 (+35.93 pp).
- The Q1 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q4 2024.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q4 2025 (a gain of 46.92 percentage points), and the weakest in Q4 2024 (a drop of 50.36 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Armata Pharmaceuticals | 137.07 Mn | 84.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -58.07% |
| Dec 31, 2025 | -49.34% |
| Dec 31, 2024 | -96.26% |
| Dec 31, 2023 | -45.89% |
| Sep 30, 2023 | -48.93% |
| Jun 30, 2023 | -74.72% |
| Mar 31, 2023 | -77.65% |
| Dec 31, 2022 | -53.17% |
| Sep 30, 2022 | -36.32% |
| Jun 30, 2022 | -31.12% |
| Mar 31, 2022 | -32.91% |
| Dec 31, 2021 | -46.34% |
| Sep 30, 2021 | -60.23% |
| Jun 30, 2021 | -53.08% |
| Mar 31, 2021 | -53.64% |
| Dec 31, 2020 | -60.15% |
| Sep 30, 2020 | -48.18% |
| Jun 30, 2020 | -49.70% |
| Mar 31, 2020 | -74.71% |
| Dec 31, 2019 | -87.79% |
API Access
Armata Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ARMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ARMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ARMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();